RA, juvenile RA, OA (arthrosis, degenerative joint disease), ankylosing spondylitis, acute musculoskeletal disorders, acute gout, pain after operative intervention &, following acute trauma, primary dysmenorrhea in patients &ge,12 yr, relief of fever &, pain associated w/ acute upper resp tract inflammation
Place of Origin
United Kingdom
Product Usage
RA, OA, ankylosing spondylitis 20 mg as a single daily dose. Acute gout Initially 40 mg as a single dose followed by 40 mg daily as a single or divided doses on the next 4-6 days. Acute musculoskeletal disorders Initially 40 mg daily for the 1st 2 days in single or divided doses. Reduce to 20 mg daily for the remainder of 7-14 days. Post-op & post-traumatic pain 20 mg as a single daily dose. Dysmenorrhea Initially 40 mg as a single daily dose for the 1st 2 days, may be continued thereafter w/ 20 mg as a single daily dose for the next 1-3 days as necessary. Upper resp tract inflammation 10 or 20 mg once daily for 5-7 days. Juvenile RA ?46 kg 20 mg/day, 26-45 kg 15 mg/day, 16-25 kg 10 mg/day, ›15 kg 5 mg/day.
Ingredients
Piroxicam
Warnings
Hypersensitivity to piroxicam. Cross sensitivity to aspirin & other NSAIDs. History of CVA
Width
1
Height
1
Depth
1